^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Yuanruida (inaticabtagene autoleucel)

    i
    Other names: CNCT19, CNCT 19, HY001, CNCT-19, inati-cel
    Associations
    News
    Trials
    Company:
    CASI, Juventas Cell Therapy
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials